Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon

Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon

Show other versions (1)

This report describes the development of hemolysis in eighteen glucose-6-phosphate dehydrogenase deficient patients treated for Plasmodium vivax malaria with chloroquine and primaquine. The most frequent findings accompanying hemolysis were fever and leukocytosis, in addition to anemia requiring red...

Full description

Bibliographic Details
Main Authors:	Wilson M Ramos Júnior, José FJ Sardinha, Mônica RF Costa, Marli S Santana, Maria GC Alecrim, Marcus VG Lacerda
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	malaria Plasmodium vivax treatment primaquine hemolysis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000400017&lng=en&tlng=en

Similar Items

Primaquine in vivax malaria: an update and review on management issues
by: Fernando Deepika, et al.
Published: (2011-12-01)

Severe Plasmodium vivax Malaria, Brazilian Amazon
by: Márcia A. Alexandre, et al.
Published: (2010-10-01)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
by: A. Taylor Bright, et al.
Published: (2013-05-01)

Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India
by: Manju Rahi, et al.
Published: (2023-06-01)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Agus Setyadi, et al.
Published: (2019-04-01)

Pharmacokinetics of chloroquine and primaquine in healthy volunteers
by: André Daher, et al.
Published: (2022-01-01)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
by: Pavani Reddy, et al.
Published: (2006-11-01)

Evaluation of Plasmodium vivax malaria recurrence in Brazil
by: André Daher, et al.
Published: (2019-01-01)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
by: Ebstie YA, et al.
Published: (2016-07-01)

A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India
by: Kavitha Saravu, et al.
Published: (2018-09-01)

Recurrencias de malaria por Plasmodium vivax según el uso de primaquina: análisis de estudios descriptivos longitudinales Plasmodium vivax malaria recurrence according to the use of primaquine: analysis of longitudinal descriptive studies
by: Jaime Carmona-Fonseca
Published: (2012-09-01)

Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
by: Francisco Javier López-Antuñano
Published: (1999-10-01)

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
by: Parinaz Mehdipour, et al.
Published: (2023-10-01)

Relapse of imported <it>Plasmodium vivax</it> malaria is related to primaquine dose: a retrospective study
by: Townell Nicola, et al.
Published: (2012-06-01)

Subdoses of primaquine in overweight patients and malaria vivax relapses: report of two cases in the Federal District, Brazil Subdoses de primaquina associadas a recaídas de malária vivax em pacientes com peso elevado: relato de dois casos no Distrito Federal
by: João Barberino Santos, et al.
Published: (2010-12-01)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
by: Chamnanphon M, et al.
Published: (2020-01-01)

Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
by: López-Antuñano Francisco Javier
Published: (1999-01-01)

On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR
by: Anatoly V. Kondrashin, et al.
Published: (2018-10-01)

Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
by: Alexandra Martin Ramírez, et al.
Published: (2020-07-01)

Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report
by: Deepali Savargaonkar, et al.
Published: (2017-01-01)

Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
by: Mac Donald-Ottevanger MS, et al.
Published: (2017-12-01)

Management of Plasmodium vivax risk and illness in travelers
by: J. Kevin Baird
Published: (2017-03-01)

Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trial
by: Hui Liu, et al.
Published: (2024-01-01)

Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine
by: Erika L. Flannery, et al.
Published: (2022-09-01)

A clinical tool to predict Plasmodium vivax recurrence in Malaysia
by: Norliza Mat Ariffin, et al.
Published: (2017-12-01)

Performance of an immunochromatography test for vivax malaria in the Amazon region, Brazil Desempenho de um teste de imunocromatografia para malária por P. vivax na Amazônia
by: Alberto Ferreira Figueiredo Filho, et al.
Published: (2003-06-01)

Performance of an immunochromatography test for vivax malaria in the Amazon region, Brazil
by: Alberto Ferreira Figueiredo Filho, et al.

Performance of an immunochromatography test for vivax malaria in the Amazon region, Brazil
by: Alberto Ferreira Figueiredo Filho, et al.
Published: (2003-06-01)

Short-course, high-dose primaquine regimens for the treatment of liver-stage vivax malaria in children
by: Brioni R. Moore, et al.
Published: (2023-09-01)

Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon
by: Wilson M. Ramos Júnior, et al.
Published: (2010-07-01)

The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
by: Koukeo Phommasone, et al.
Published: (2020-01-01)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
by: Walter Robert Taylor, et al.
Published: (2021-09-01)

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
by: Robert J. Commons, et al.
Published: (2019-08-01)

Performance of an immunochromatography test for vivax malaria in the Amazon region, Brazil
by: Figueiredo Filho Alberto Ferreira, et al.
Published: (2003-01-01)

Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing
by: Annie N. Cowell, et al.
Published: (2018-07-01)

Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study
by: Joabi Rocha Nascimento, et al.
Published: (2022-08-01)

A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India
by: Sundus Shafat Ahmad, et al.
Published: (2024-02-01)

Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment
by: Sze-Ann Woon, et al.
Published: (2023-05-01)

Slow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon
by: André M Siqueira, et al.
Published: (2014-08-01)

CYP2D6 Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar
by: Rajeev K. Mehlotra, et al.
Published: (2021-04-01)